MMSI MERIT MEDICAL SYSTEMS INC — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$73.48

Period return

-9.91 (-11.88%)

Volume

825.3K

2026-07-21O $74.13 H $75.17 L $73.33 C $73.48MA5 $74.25MA20 $71.7MA60 $66.66MA120 $70.22

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 07. 30.Highin 9 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 02.LowBUY3 months ago
Canaccord Genuity: Buy
US analyst rating / recommendation change.
2026. 05. 02.LowBUY3 months ago
JP Morgan: Overweight
US analyst rating / recommendation change.
2026. 05. 01.LowHOLD3 months ago
Wells Fargo: Equal-Weight
US analyst rating / recommendation change.
2026. 05. 01.LowBUY3 months ago
Needham: Buy
US analyst rating / recommendation change.
2026. 04. 20.LowBUY3 months ago
Barrington Research: Outperform
US analyst rating / recommendation change.
2026. 04. 18.LowBUY3 months ago
Piper Sandler: Overweight
US analyst rating / recommendation change.
2026. 04. 07.LowBUY4 months ago
Canaccord Genuity: Buy
US analyst rating / recommendation change.
2026. 04. 01.LowBUY4 months ago
Needham: Buy
US analyst rating / recommendation change.
2026. 02. 26.MediumHOLD5 months ago
Wells Fargo: Equal-Weight
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $90.64 · 11 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 07. 30.	After market close (AMC)	$0.96	—	—	$405.28M	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$0.49	—	—	$355.35M	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$1.57	—	—	$1B	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$1.09	—	—	$661.51M	Reported

MERIT MEDICAL SYSTEMS INC

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 02.	Canaccord Genuity	—	Maintain	Buy → Buy	—	Canaccord Genuity: Buy
2026. 05. 02.	JP Morgan	—	Maintain	Overweight → Overweight	—	JP Morgan: Overweight
2026. 05. 01.	Wells Fargo	—	Maintain	Equal-Weight → Equal-Weight	—	Wells Fargo: Equal-Weight
2026. 05. 01.	Needham	—	Maintain	Buy → Buy	—	Needham: Buy
2026. 04. 20.	Barrington Research	—	Maintain	Outperform → Outperform	—	Barrington Research: Outperform
2026. 04. 18.	Piper Sandler	—	Maintain	Overweight → Overweight	—	Piper Sandler: Overweight